Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2018-06, Vol.53 (6), p.795-799
Hauptverfasser:	Gatwood, Katie S., Culos, Kathryn A., Binari, Laura A., Engelhardt, Brian G., Kassim, Adetola, Byrne, Michael T., Goodman, Stacey A., Chinratanalab, Wichai, Sengsayadeth, Salyka M., Greer, John P., Jagasia, Madan, Savani, Bipin N.
Format:	Artikel
Sprache:	eng
Schlagworte:	692/700/565 692/700/565/1436/99 Anemia Anemia, Aplastic - drug therapy Anemia, Aplastic - therapy Antineoplastic agents Aplastic anemia Cell Biology Correspondence Drugstores Female Health aspects Hematology Hematopoietic stem cell transplantation Hematopoietic Stem Cell Transplantation - methods Humans Internal Medicine Male Medical centers Medicine Medicine & Public Health Monoclonal antibodies Pharmacy Public Health Rituximab Rituximab - administration & dosage Stem cell transplantation Stem Cells Surgery Transplantation Transplantation Conditioning - methods Universities and colleges
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!